期刊文献+

新疆维吾尔族妇女宫颈癌组织HPV16型E6基因变异分析 被引量:7

Analysis of mutations in the E6 oncogene of human papillomavirus 16 in Xinjiang Uygur women with cervical carcinoma
下载PDF
导出
摘要 目的:新疆维吾尔族妇女宫颈癌的发生主要与人乳头状瘤病毒16(HPV16)感染相关,特定的HPV16E6突变株具有更高的致癌危险性。本研究通过检测维吾尔族妇女宫颈癌组织中HPV16E6基因突变情况,探讨其与维吾尔族妇女宫颈癌高发的关系。方法:从140例维吾尔族妇女宫颈癌石蜡包埋组织中提取DNA作为模板,PCR扩增HPV16E6全长基因,PCR产物直接测序,进行突变分析。结果:本组维吾尔族妇女宫颈癌组织中HPV16的阳性率是73.6%(103/140),91例E6基因测序及分析结果表明,维吾尔族妇女宫颈癌组织中存在HPV16E6变异株,其中49例(53.8%)分离株发生L83V突变,4例(4.39%)发生D25E突变,2例(2.20%)发生D64E/L83V突变,36例(39.6%)与野生型相同。结论:新疆维吾尔族妇女宫颈癌患者HPV16E6基因发生变异,主要以L83V突变为主,HPV16变异株在维吾尔族妇女宫颈癌患者中的分布可能与维吾尔族妇女宫颈癌高发存在一定关系。 Objective:High-risk human papillomaviruses( HRHPVs), especially HPV16, is the major cause of cervical carcinoma(CC) in Xinjing Uygur women. In some region, specific E6 mutation is considered as dangerous factor causing CC. This study was designed to investigate distribution of HPV16 mutation and the relationship between the mutation and high incidence of CC in Uygur women. Methods :The tissue DNA was extracted from 140 CC paraffin embedded tissue of Uygur women. HPV16 E6 gene was amplified by polymerase chain reaction(PCR) from the CC tissue DNA. The PCR fragments were sequenced and analyzed. Results:The result of PCR showed that the positive rate of HPV16 was 73.5% (103/140) ; Ninty-one of 97 PCR fragments were sequenced and analyzed. Thirty-six of them maintained prototype(39. 6% ). Forty-nine have L83V mutation(53.6% ) and 4 have D25E(4. 25% ), and 2 have L83V/D64E(2. 27% ). Conclusion:There are mutations within the HPV16 E6 gene in CC of Xinjiang Uygur women. The most common mutation was L83V. Our research suggested that the distribution of HPV16 E6 mutation might be associated with high incidence of CC in Uygur.
出处 《临床肿瘤学杂志》 CAS 2008年第3期209-212,共4页 Chinese Clinical Oncology
基金 新疆维吾尔自治区自然科学基金资助项目(NO.200521107)
关键词 宫颈癌 人乳头状瘤病毒 E6基因 基因突变 Cervical carcinoma Human papillomavirus E6 gene Gene mutation
  • 相关文献

参考文献10

  • 1Nicolas FS, Andrea T, Eliane DF, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia[ J]. Int J Cancer, 2003, 103(4) : 519 -524.
  • 2Burd EM. Human papillomavirus and cervical cancer[ J]. Clin Microbiol Rev, 2003, 16(1) : 1 -17.
  • 3古扎丽努尔.阿不力孜,彭芝兰,刘珊玲,王和.HPV及其亚型在四川西北地区汉族及新疆南部地区维吾尔族妇女宫颈癌组织中的差异表达[J].中华微生物学和免疫学杂志,2004,24(5):408-408. 被引量:32
  • 4马正海,张富春,梅新娣,马彩玲,刘开江.新疆维吾尔族妇女宫颈癌组织中HPV16型E6基因突变分析[J].癌症,2004,23(9):1016-1020. 被引量:17
  • 5Brule AJ, Pol R, Fransen-Daalmeijer N, et al. GP5 +/6 + PCR followed by reverse line blot analysis enables rapid and highthroughput identification of human papillomavirus genotypes [ J ]. J Clin Microbiol, 2002, 40(3) :779 -787.
  • 6Del Refugio GLM, Laviada M, Teran MA, et al. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasivecancer[ J]. J Clin Virol, 2004,29(2) :95 -98.
  • 7Kang S, Jeon YT, Kim JW, et al. Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women[J]. Int J Gynecol Cancer, 2005, 15( 1 ) : 107 - 112.
  • 8Tornesello ML, Duraturo ML, Salatiello I, et al. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer[ J]. J Med Virol, 2004, 74(1):117-126.
  • 9Martha G, Guillaume B, Christine C, et al. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16E6-350G variant[J]. Cancer Epidemiol Biomarkers Prev, 2006,15 (4): 820 - 822.
  • 10Zehbe I, Mytilineos J, Wikstrom I, et al. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women [J]. Hum Immunol,2003, 64(5) :538 -542.

二级参考文献18

  • 1李庭芳,古力娜.库尔班,古丽沙热,贺国丽,王涛,海日古丽,王振华.新疆伽师县夏普桃勒乡妇女子宫颈癌防治研究[J].新疆医学院学报,1996,19(3):199-203. 被引量:64
  • 2Matsumoto K, Yoshikawa H, Nakagawa S, et al. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population [J]. Cancer Lett,2000,156:159- 165.
  • 3Londesborough P, Ho L, Terry G, et al. Human papillomavirus genotype as a predictor of persistence and development of high grade lesions in women with minor cervical abnormalities [J]. Int J Cancer, 1996, 69:364- 368.
  • 4Zehbe I, Wilander E, Delius H, et al. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype [J]. Cancer Res, 1998, 58:829- 833.
  • 5Zehbe I, Voglino G, Wilander E, et al. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development [J]. Cancer Res, 2001, 61:608- 611.
  • 6Zehbe I, Voglino G, Delius H, et al. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms [J]. Lancet, 1998, 352:1441- 1442.
  • 7Zehbe I, Tachezy R, Mytilineos J. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes [J]. Int J Cancer, 2001, 94:711- 716.
  • 8Matsumoto K, Yasugi, Nakagawa S. Human papillomavirus 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer [J]. Int J Cancer, 2003, 106:919- 922.
  • 9Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta analysis [J]. Br J Cancer, 2003, 88:63- 73.
  • 10Hwang TS, Jeong JK, Park M, et al. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray [J]. Gynecol Oncol, 2003,90:51- 56.

共引文献47

同被引文献67

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部